Literature DB >> 15643613

Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.

Zhengwen Jiang1, Timothy P Dalton, Li Jin, Bin Wang, Yutaka Tsuneoka, Howard G Shertzer, Ranjan Deka, Daniel W Nebert.   

Abstract

Interindividual differences in human CYP1A1 and CYP1A2 expression appear to be associated with variability in risk toward various types of environmental toxicity and cancer. These two genes are oriented head-to-head on human chromosome 15; the 23.3-kb spacer region might contain distinct regulatory regions for CYP1A1 and distinct regulatory regions for CYP1A2, or the regulatory regions for the two genes might overlap one another. From 24 unrelated subjects of five major, geographically-isolated subgroups, we resequenced both genes (all exons and all introns) plus some 3' flanking sequences and the entire spacer region (39.6 kb total); 85 SNPs were found, 49 of which were not currently in the National Center for Biotechnology Information (NCBI) database. Of the 57 double-hit SNPs, we carried out SNP-typing in 94 Africans, 96 Asians, and 83 Caucasians and found striking ethnic differences in SNP frequencies and haplotype evolution; the two CYP1A1 SNPs and the one CYP1A2 SNP that are most commonly used in epidemiological studies were shown not to be representative haplotype tag SNPs across these three human subgroups. Four BAC-transgenic mouse lines, carrying the human CYP1A2 and 15,190 bp of 5' flank, expressed only negligible basal or inducible CYP1A2 mRNA. A fifth BAC-transgenic mouse line, carrying both the human CYP1A1 and CYP1A2 genes and ample amounts of 3' flanking sequences, plus all of the spacer region--in the absence of the mouse Cyp1a1 or Cyp1a2 genes--expressed the human CYP1A1 and CYP1A2 mRNA, protein and enzyme activities in liver and nonhepatic tissues very similar to that of the mouse. Comparison of this hCYP1A1_1A2 transgenic line with hCYP1A1_1A2 lines carrying other common human haplotypes will enable us to evaluate function in human CYP1A1_CYP1A2 locus variability, with regard to toxicity and cancer caused by combustion products. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643613     DOI: 10.1002/humu.20134

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  27 in total

Review 1.  Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity.

Authors:  Stephen C Strom; Julio Davila; Markus Grompe
Journal:  Methods Mol Biol       Date:  2010

2.  Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.

Authors:  Senad Divanovic; Jesmond Dalli; Lucia F Jorge-Nebert; Christopher L Karp; Charles N Serhan; Daniel W Nebert; Leah M Flick; Marina Gálvez-Peralta; Nicholas D Boespflug; Traci E Stankiewicz; Jonathan M Fitzgerald; Maheshika Somarathna
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

Review 3.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

4.  Generation and characterization of a CYP2A13/2B6/2F1-transgenic mouse model.

Authors:  Yuan Wei; Hong Wu; Lei Li; Zhihua Liu; Xin Zhou; Qing-Yu Zhang; Yan Weng; Jaime D'Agostino; Guoyu Ling; Xiuling Zhang; Kerri Kluetzman; Yunyi Yao; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2012-03-07       Impact factor: 3.922

Review 5.  Polycyclic aromatic hydrocarbons: from metabolism to lung cancer.

Authors:  Bhagavatula Moorthy; Chun Chu; Danielle J Carlin
Journal:  Toxicol Sci       Date:  2015-05       Impact factor: 4.849

6.  Generation of a 'humanized' hCYP1A1_1A2_Cyp1a1/1a2(-/-)_Ahrd mouse line harboring the poor-affinity aryl hydrocarbon receptor.

Authors:  Zhanquan Shi; Ying Chen; Hongbin Dong; Robyn M Amos-Kroohs; Daniel W Nebert
Journal:  Biochem Biophys Res Commun       Date:  2008-09-22       Impact factor: 3.575

7.  CYP1A1 and CYP1A2 expression: comparing 'humanized' mouse lines and wild-type mice; comparing human and mouse hepatoma-derived cell lines.

Authors:  Shigeyuki Uno; Kaori Endo; Yuji Ishida; Chise Tateno; Makoto Makishima; Katsutoshi Yoshizato; Daniel W Nebert
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-10       Impact factor: 4.219

8.  Knock-in mouse lines expressing either mitochondrial or microsomal CYP1A1: differing responses to dietary benzo[a]pyrene as proof of principle.

Authors:  Hongbin Dong; Timothy P Dalton; Marian L Miller; Ying Chen; Shigeyuki Uno; Zhanquan Shi; Howard G Shertzer; Seema Bansal; Narayan G Avadhani; Daniel W Nebert
Journal:  Mol Pharmacol       Date:  2008-12-01       Impact factor: 4.436

9.  CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification.

Authors:  Melinda C Aldrich; Steve Selvin; Helen M Hansen; Lisa F Barcellos; Margaret R Wrensch; Jennette D Sison; Karl T Kelsey; Patricia A Buffler; Charles P Quesenberry; Michael F Seldin; John K Wiencke
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.

Authors:  Sara E Bass; Pawel Sienkiewicz; Christopher J Macdonald; Robert Y S Cheng; Anna Sparatore; Piero Del Soldato; David D Roberts; Terry W Moody; David A Wink; Grace Chao Yeh
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.